Status:

COMPLETED

Mifepristone and Mid-Trimester Termination of Pregnancy

Lead Sponsor:

Boston University

Conditions:

Abortion, Induced

Abortion, Second Trimester

Eligibility:

FEMALE

16-45 years

Phase:

NA

Brief Summary

Mid-second trimester medical terminations of pregnancy require admission to the hospital for the length of time it takes a woman to abort. The current protocol at BMC uses intra-amniotic digoxin injec...

Detailed Description

This is a randomized, placebo-controlled, double-blinded study. Allocation Method: Women will be randomized using a computer-run random number table. Tablets will be placed in capsules by the pharmac...

Eligibility Criteria

Inclusion

  • 16 years of age or over
  • able to give informed consent in English or Spanish
  • Requesting termination of pregnancy

Exclusion

  • Under 16 years of age
  • rupture membranes or intrauterine death

Key Trial Info

Start Date :

March 1 2005

Trial Type :

INTERVENTIONAL

End Date :

November 1 2006

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT00382538

Start Date

March 1 2005

End Date

November 1 2006

Last Update

October 7 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Boston Medical Center

Boston, Massachusetts, United States, 02118

Mifepristone and Mid-Trimester Termination of Pregnancy | DecenTrialz